Novarapid Penfil 100 mg Injection 1's is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above two years of age) and adults. The active ingredient in Novarapid Penfil 100 mg Injection 1's is insulin aspart. Diabetes is a medical condition where your body does not produce enough insulin to control your blood sugar level. Treatment with Novarapid Penfil 100 mg Injection 1's helps to prevent complications from your diabetes.

When Novarapid Penfil 100 mg Injection 1's is injected, it is extremely fast-acting and works rapidly to normalise blood sugar levels. It typically begins working after 10-20 minutes and will last for between 3 and 5 hours. Due to this short action, Novarapid Penfil 100 mg Injection 1's should normally be taken in combination with intermediate-acting or long-acting insulin preparations. Novarapid Penfil 100 mg Injection 1's works by ensuring rapid and consistent sugar control. Novarapid Penfil 100 mg Injection 1's is a fast-acting form of insulin that helps lower blood sugar levels after food intake. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver.

Your doctor will advise you on how to use Novarapid Penfil 100 mg Injection 1's. It should be administered at least 5-10 minutes before the meal or within 20 minutes after you start having a meal. The common side effects of Novarapid Penfil 100 mg Injection 1's are hypokalaemia (low potassium), hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin), which may occur at the injection site. Most of these side effects of Novarapid Penfil 100 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking Novarapid Penfil 100 mg Injection 1's of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Do not take Novarapid Penfil 100 mg Injection 1's if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs. Along with Novarapid Penfil 100 mg Injection 1's, you should take a healthy diet, exercise regularly, and maintain weight as your doctor advises. Novarapid Penfil 100 mg Injection 1's is a cold chain medicine, so it must be stored in the refrigerator between 2-8 degrees Celsius; otherwise, its efficiency might get lost. Do not store it in the freezer of the fridge.

Novarapid Penfil 100 mg Injection 1's works by ensuring rapid and consistent sugar control. Novarapid Penfil 100 mg Injection 1's is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver. Novarapid Penfil 100 mg Injection 1's helps in improving the glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage to the retina (retinopathy), damage to the kidney (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others. Besides this, Novarapid Penfil 100 mg Injection 1's can be safely prescribed to the diabetic mother during pregnancy and lactation.

• Hypokalaemia (low potassium)
• Hypoglycaemia (low blood sugar level)
• Local injection site reactions
• Lipodystrophy (fat deposition under the skin)
• Rash
• Pruritus (itchy skin)

Novarapid Penfil 100 mg Injection 1's is for subcutaneous (under the skin) use only and should never be administered intravenously (IV) or in the veins. If you are changing the brand of insulin or if you need to inject your insulin by another method, it should be done under strict medical supervision. Cases of heart failure were reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Novarapid Penfil 100 mg Injection 1's may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take Novarapid Penfil 100 mg Injection 1's if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs.

Drug-Drug Interactions: Novarapid Penfil 100 mg Injection 1's may have an interaction with drugs that may increase the risk of antiarrhythmic (disopyramide), hemorrheologic agents (pentoxifylline), antidiabetic (pramlintide), bleeding disorder drugs (octreotide), antipsychotic (propoxyphene, phenothiazines), female sex hormones (progestogen, oestrogen), thyroid hormones (levothyroxine), anti-asthmatics (albuterol, epinephrine, terbutaline), an antidepressant (fluoxetine, lithium), lipid-lowering pills (reserpine, niacin, clonidine, fenofibrate, guanethidine), pain killers (aspirin), antibiotics (isoniazid), blood sugar enhancing pills (glucagon), male hormone testosterone analogue (danazol), antibiotic (pentamidine).

Drug-Food Interactions: Novarapid Penfil 100 mg Injection 1's may interact with an ayurvedic, homoeopathy, Unani, herbal supplements or OTC items. Tell your doctor if you are using these products. Try to avoid intake of alcoholic beverages with Novarapid Penfil 100 mg Injection 1's as it may increase or decrease your blood sugar level.

Drug-Disease Interactions: Novarapid Penfil 100 mg Injection 1's should not be given to patients with kidney disease, liver disease, low blood sugar/glucose level (hypoglycaemia), and low potassium level (hypokalaemia).

• ASPIRIN
• FUROSEMIDE
• METOPROLOL
• LEVOTHYROXINE SODIUM

• Exercise may lower your body’s need for insulin during and sometimes after physical activity.
• Exercise may also speed up the effect of an insulin dose, especially if the exercise involves the area of the injection site (for example, the leg should not be used for injection just before running).
• Discuss with your doctor how to adjust your insulin regimen to accommodate exercise. 
• Avoid eating sugar food and prefer food cooked food low in calories.
• When travelling across more than two time zones, you should talk to your doctor concerning adjustments in your insulin schedule.

• Your doctor may tell you to have a normal potassium level as prolonged administration causes a life-threatening condition of hypokalemia (low potassium). 
• Always sterilize the injection site before administration of the drug.

Diabetes: Diabetes is a chronic or lifelong disease that prevents the body from utilizing insulin properly. Insulin is the hormone that controls sugar levels in the blood. Diabetes is a condition in which blood glucose levels are above normal. It is of two types, namely: type-1 and type-2 diabetes. Type-1 diabetes is a condition in which the pancreas produces little or no insulin. Type-2 diabetes affects the way the body processes sugar. Symptoms of diabetes include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, weight loss, and itchy skin.